Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.12e-20	114	175	20	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.47e-20	124	175	20	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	5.07e-19	137	175	20	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L7 USP17L21 USP17L4 SCRN3 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 PDIA3 USP17L18 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.74e-18	192	175	22	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L7 PRSS54 USP17L21 USP17L4 SCRN3 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 PDIA3 USP17L18 TGM2 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.09e-09	654	175	24	GO:0008233
GeneOntologyMolecularFunction	L-lactate dehydrogenase activity	LDHA LDHB LDHC	6.53e-06	5	175	3	GO:0004459
GeneOntologyMolecularFunction	lactate dehydrogenase activity	LDHA LDHB LDHC	1.30e-05	6	175	3	GO:0004457
GeneOntologyMolecularFunction	ATP-dependent activity	KIF6 PMS2 SMARCA5 MYH10 ATP7B MYO9A ABCA13 TCIRG1 MMAA ORC4 ATAD3A DNAH17 UBA6 HSPA9 XRCC6 HSP90AA1 SLC27A2	2.97e-05	614	175	17	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal protein binding	KIF6 MYH10 PDE4B ANK2 MYO9A RPS3 OBSCN ADGRV1 PPARG EPB41L3 KRIT1 KLHL3 DST ANKRD2 SYNE2 FMN2 CDK5RAP2 SNTA1 PACSIN2 HSP90AA1 NIN	6.50e-04	1099	175	21	GO:0008092
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.10e-20	125	175	20	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.57e-19	144	175	20	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L7 CUL3 UBR2 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 RPS3 USP17L11 USP17L24 USP17L5 USP17L19 RAB40A USP17L18 CUL5 KLHL3 USP5 USP17L17 RAB40AL USP17L6P UBA6 USP17L3 TNKS USP17L22 USP17L15 HSP90AA1 USP17L8 USP17L13	1.83e-09	1009	175	30	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L7 CUL3 UBR2 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 RPS3 USP17L11 USP17L24 USP17L5 USP17L19 RAB40A FN3K USP17L18 CUL5 KLHL3 USP5 USP17L17 RAB40AL USP17L6P UBA6 USP17L3 TNKS USP17L22 USP17L15 HSP90AA1 USP17L8 USP17L13	1.92e-09	1074	175	31	GO:0043687
GeneOntologyBiologicalProcess	lactate biosynthetic process from pyruvate	LDHA LDHB LDHC	2.39e-06	4	175	3	GO:0019244
GeneOntologyBiologicalProcess	lactate biosynthetic process	LDHA LDHB LDHC	2.05e-05	7	175	3	GO:0019249
GeneOntologyBiologicalProcess	protein localization to M-band	ANK2 OBSCN	7.16e-05	2	175	2	GO:0036309
GeneOntologyBiologicalProcess	cytoskeleton-dependent cytokinesis	CHMP4C MYH10 RASA1 CHMP1B ORC4 FMN2 SHCBP1L	1.07e-04	127	175	7	GO:0061640
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L7 USP17L21 USP17L4 ATP6AP1 CYP26B1 USP17L2 USP17L12 USP17L1 CYP2J2 USP17L20 USP17L11 VPS13C SREBF2 USP17L5 USP17L19 CYP39A1 PDIA3 ITPR3 USP17L18 THADA DST USP17L17 SYNE2 UGT2B4 USP17L6P USP17L3 FMN2 UGT2B28 USP17L22 POMK FAM8A1 USP17L15 USP17L8 SLC27A2 USP17L13	4.74e-10	1293	174	35	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L7 USP17L21 USP17L4 ATP6AP1 CYP26B1 USP17L2 USP17L12 USP17L1 CYP2J2 USP17L20 USP17L11 VPS13C SREBF2 USP17L5 USP17L19 CYP39A1 PDIA3 ITPR3 USP17L18 THADA DST USP17L17 SYNE2 UGT2B4 USP17L6P USP17L3 FMN2 UGT2B28 USP17L22 POMK FAM8A1 USP17L15 USP17L8 SLC27A2 USP17L13	5.37e-10	1299	174	35	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L7 USP17L21 USP17L4 ATP6AP1 CYP26B1 USP17L2 USP17L12 USP17L1 CYP2J2 USP17L20 USP17L11 VPS13C SREBF2 USP17L5 USP17L19 CYP39A1 PDIA3 ITPR3 USP17L18 THADA DST USP17L17 SYNE2 UGT2B4 USP17L6P USP17L3 FMN2 UGT2B28 USP17L22 POMK FAM8A1 USP17L15 USP17L8 SLC27A2 USP17L13	9.44e-10	1327	174	35	GO:0042175
GeneOntologyCellularComponent	nuclear envelope	CHMP4C RASA1 LEMD3 CHMP1B RAB40A ITPR3 DST SYNE2 RAB40AL DPY19L4 NUP133 UGT2B4 ANKRD17 TNKS UGT2B28	7.26e-05	560	174	15	GO:0005635
GeneOntologyCellularComponent	perinuclear region of cytoplasm	ADCY10 PDE4B ATP7B ANK2 KALRN ADGRV1 PPARG RAB40A EPG5 ITPR3 TGM2 DST RAB40AL FMN2 CDK5RAP2 PRKD1 UGT2B28 DOCK6 WWC1 HSP90AA1	1.04e-04	934	174	20	GO:0048471
GeneOntologyCellularComponent	nuclear outer membrane	ITPR3 SYNE2 UGT2B4 UGT2B28	3.35e-04	40	174	4	GO:0005640
GeneOntologyCellularComponent	organelle envelope	CHMP4C SLC25A24 RASA1 LEMD3 CHMP1B RPS3 VPS13C STARD7 RAB40A LDHB NDUFS2 ITPR3 DST ATAD3A SYNE2 RAB40AL DPY19L4 NUP133 UGT2B4 ANKRD17 TNKS HADHA UGT2B28 PC HSPA9	3.57e-04	1435	174	25	GO:0031967
GeneOntologyCellularComponent	postsynaptic density	PDE4B ANK2 KALRN RPS3 ADGRB3 SYNDIG1 GRIK2 PAK6 EPB41L3 NEO1 DST TRAPPC4	4.12e-04	451	174	12	GO:0014069
GeneOntologyCellularComponent	I band	PDE4B ANK2 OBSCN DST ANKRD2 SYNE2 PRKD1	4.91e-04	166	174	7	GO:0031674
GeneOntologyCellularComponent	axonal growth cone	MYO9A NEO1 HSP90AA1 NIN	5.29e-04	45	174	4	GO:0044295
GeneOntologyCellularComponent	asymmetric synapse	PDE4B ANK2 KALRN RPS3 ADGRB3 SYNDIG1 GRIK2 PAK6 EPB41L3 NEO1 DST TRAPPC4	6.75e-04	477	174	12	GO:0032279
GeneOntologyCellularComponent	nuclear membrane	RASA1 LEMD3 ITPR3 SYNE2 DPY19L4 NUP133 UGT2B4 ANKRD17 TNKS UGT2B28	7.11e-04	349	174	10	GO:0031965
GeneOntologyCellularComponent	postsynaptic specialization	PDE4B ANK2 KALRN RPS3 ADGRB3 SYNDIG1 GRIK2 PAK6 EPB41L3 NEO1 DST TRAPPC4	1.07e-03	503	174	12	GO:0099572
MousePheno	increased trophectoderm apoptosis	SMARCA5 USP17L2 USP17L15 USP17L13	5.16e-07	8	132	4	MP:0012119
Domain	HABP4_PAI-RBP1	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	1.19e-27	16	165	14	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L7 USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	1.19e-27	16	165	14	IPR006861
Domain	UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	8.65e-22	71	165	18	PF00443
Domain	USP_2	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	8.65e-22	71	165	18	PS00973
Domain	USP_3	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.14e-21	72	165	18	PS50235
Domain	USP_dom	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.14e-21	72	165	18	IPR028889
Domain	Peptidase_C19_UCH	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	1.14e-21	72	165	18	IPR001394
Domain	USP_CS	USP17L7 USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	9.08e-21	66	165	17	IPR018200
Domain	USP_1	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 USP17L22 USP17L8 USP17L13	2.76e-20	70	165	17	PS00972
Domain	L_LDH	LDHA LDHB LDHC	6.68e-06	5	165	3	PS00064
Domain	L-lactate_DH	LDHA LDHB LDHC	6.68e-06	5	165	3	IPR011304
Domain	L-lactate_DH_AS	LDHA LDHB LDHC	6.68e-06	5	165	3	IPR018177
Domain	Lactate/malate_DH_N	LDHA LDHB LDHC	3.67e-05	8	165	3	IPR001236
Domain	L-lactate/malate_DH	LDHA LDHB LDHC	3.67e-05	8	165	3	IPR001557
Domain	Ldh_1_N	LDHA LDHB LDHC	3.67e-05	8	165	3	PF00056
Domain	-	LDHA LDHB LDHC	5.47e-05	9	165	3	3.90.110.10
Domain	Lactate/malate_DH_C	LDHA LDHB LDHC	5.47e-05	9	165	3	IPR022383
Domain	Ldh_1_C	LDHA LDHB LDHC	5.47e-05	9	165	3	PF02866
Domain	Lactate_DH/Glyco_Ohase_4_C	LDHA LDHB LDHC	5.47e-05	9	165	3	IPR015955
Pathway	REACTOME_RAS_PROCESSING	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.92e-25	45	140	18	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 RIPK1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 TNKS USP17L22 USP17L15 USP17L8 USP17L13	2.26e-16	191	140	21	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 RIPK1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 TNKS USP17L22 USP17L15 USP17L8 USP17L13	5.36e-14	221	140	20	M27578
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L7 CUL3 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 RASA1 KALRN USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 MAPK12 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 APBB1IP USP17L8 USP17L13	7.32e-14	318	140	23	MM15278
Pathway	REACTOME_DEUBIQUITINATION	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 RIPK1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L6P USP17L3 TNKS USP17L22 USP17L15 USP17L8 USP17L13	1.33e-13	262	140	21	MM15286
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 RIPK1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP5 USP17L17 USP17L3 TNKS USP17L22 USP17L15 USP17L8 USP17L13	1.51e-11	299	140	20	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	CUL3 USP17L21 USP17L4 USP17L2 USP17L12 ANK2 USP17L1 RIPK1 USP17L20 USP17L11 GOSR1 USP17L24 USP17L5 USP17L19 PPARG RAB40A PDIA3 TFAP2B FN3K USP17L18 CUL5 KLHL3 EDEM3 USP5 USP17L17 NR5A2 NUP133 UBA6 USP17L3 TRAPPC4 TNKS USP17L22 POMK USP17L15 USP17L8 USP17L13	2.27e-07	1475	140	36	M19806
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L7 CUL3 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 RIPK1 USP17L20 USP17L11 GOSR1 USP17L5 USP17L19 RAB40A PDIA3 FN3K USP17L18 KLHL3 USP5 USP17L17 RAB40AL NR5A2 NUP133 USP17L6P UBA6 USP17L3 TRAPPC4 TNKS USP17L22 POMK USP17L15 USP17L8 USP17L13	1.53e-06	1389	140	33	MM15307
Pathway	WP_KREBS_CYCLE_DISORDERS	LDHA LDHB LDHC	2.55e-04	13	140	3	M39769
Pathway	KEGG_PROPANOATE_METABOLISM	LDHA LDHB LDHC HADHA	3.05e-04	33	140	4	M4086
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-39	21	176	18	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-39	21	176	18	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-39	21	176	18	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-39	21	176	18	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-39	21	176	18	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-39	21	176	18	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.39e-38	22	176	18	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.54e-37	24	176	18	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	9.03e-37	25	176	18	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.92e-36	26	176	18	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.78e-36	33	176	19	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.53e-35	34	176	19	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.33e-35	35	176	19	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.33e-35	35	176	19	21239494
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	6.38e-35	29	176	18	32527007
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	7.03e-35	36	176	19	20147298
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	1.44e-34	37	176	19	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.04e-29	50	176	18	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.63e-17	10	176	8	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.78e-16	12	176	8	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	1.07e-15	14	176	8	11793228
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L7 USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15 USP17L8	2.64e-14	19	176	8	28067227
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L7 PRSS54 USP17L4 USP17L2 USP17L1 USP5 USP17L6P USP17L3 USP17L15 USP17L8	1.17e-11	81	176	10	12838346
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 S1PR1 USP17L18 TGM2 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.75e-10	674	176	20	37196079
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	LEMD3 RPS3 PPFIBP1 VPS13C GOSR1 TEX9 EPB41L3 LDHA RUFY1 LDHB SLC38A1 THADA NEO1 SF3B1 DST ANO6 CDK5RAP2 ZFHX3 PC HSPA9 HSP90AA1	5.17e-10	777	176	21	35844135
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	ATP6AP1 ANK2 LEMD3 PPFIBP1 NFS1 EPB41L3 PDIA3 NDUFS2 ITPR3 NAA35 THADA NEO1 SF3B1 ATAD3A DNAJA4 ANO6 SYNE2 PANK4 NUP133 UBA6 CDK5RAP2 HADHA HSPA9 EDRF1 XRCC6 PACSIN2 NIN	8.87e-09	1487	176	27	33957083
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	CUL3 MYH10 PDE4B ANK2 KALRN ADGRB3 GRIK2 EPB41L3 SF3B1 DST DNAJA4 SYNE2 UBA6 ANKRD17 CDK5RAP2 TNKS PRKD1 TAF5 HSPA9 XRCC6 HSP90AA1	2.21e-08	963	176	21	28671696
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	ANK2 RIPK1 MYO9A RPS3 PPFIBP1 ICE2 EPB41L3 NDUFS2 SLC38A1 DST ATAD3A UBA6 ANKRD17 HADHA HSPA9 XRCC6 PACSIN2 HSP90AA1	2.44e-08	708	176	18	39231216
Pubmed	Connecting the Dots in the Neuroglobin-Protein Interaction Network of an Unstressed and Ferroptotic Cell Death Neuroblastoma Model.	MYH10 RUFY1 LDHB PDIA3 CNTNAP4 HADHA SNRPD1 HSPA9 XRCC6	3.21e-08	135	176	9	31405213
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	SLC25A24 SMARCA5 MYH10 USP17L1 KALRN CDK12 RPS3 EPB41L3 LDHA LDHB NDUFS2 SF3B1 DST ZNF532 ATAD3A HADHA CDK11B PZP DOCK6 SNRPD1 XRCC6 HSP90AA1	3.43e-08	1082	176	22	38697112
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	ATP6AP1 ATP7B LEMD3 PPFIBP1 VPS13C GOSR1 SREBF2 ITPR3 NEO1 DST ANO6 SYNE2 FMN2 DOCK6 DOP1B	5.02e-08	504	176	15	34432599
Pubmed	SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response.	SMARCA5 MYH10 RPS3 LDHA LDHB NDUFS2 SF3B1 ATAD3A NUP133 CDK11B SNRPD1 HSPA9 XRCC6 HSP90AA1	1.17e-07	463	176	14	34901782
Pubmed	Beta-agonists enhance the lactic dehydrogenase (LDH) expression in serum and ventricular myocytes of mice.	LDHA LDHB LDHC	1.27e-07	3	176	3	17853776
Pubmed	Properties of human testis-specific lactate dehydrogenase expressed from Escherichia coli.	LDHA LDHB LDHC	1.27e-07	3	176	3	1996957
Pubmed	Developmental regulation of expression of the lactate dehydrogenase (LDH) multigene family during mouse spermatogenesis.	LDHA LDHB LDHC	1.27e-07	3	176	3	2401207
Pubmed	Increased serum lactate dehydrogenase isoenzymes in Ph-negative chronic myeloproliferative diseases: a metabolic adaptation?	LDHA LDHB LDHC	1.27e-07	3	176	3	17178662
Pubmed	Association between serum lactate dehydrogenase and 60-day mortality in Chinese Hakka patients with acute myeloid leukemia: A cohort study.	LDHA LDHB LDHC	1.27e-07	3	176	3	34708888
Pubmed	Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase.	LDHA LDHB LDHC	1.27e-07	3	176	3	11276087
Pubmed	TRIM24 is an insulin-responsive regulator of P-bodies.	MYH10 RPS3 PPARG SF3B1 ATAD3A ANKRD17 XRCC6	1.75e-07	80	176	7	35803934
Pubmed	Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase.	CUL3 MYH10 RPS3 ADGRV1 LDHA LDHB PDIA3 CUL5 MIS12 HADHA SNRPD1 HSPA9 XRCC6 HSP90AA1	2.64e-07	495	176	14	28581483
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	CUL3 MYH10 ATP6AP1 ANK2 KALRN MYO9A RPS3 EPB41L3 LDHA LDHB PDIA3 NDUFS2 CUL5 USP5 SF3B1 DST ATAD3A ITSN2 HADHA PC SNRPD1 SNTA1 HSPA9 HSP90AA1	2.77e-07	1431	176	24	37142655
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	MYH10 PPFIBP1 GOSR1 LDHA PDIA3 NDUFS2 ITPR3 CUL5 USP5 THADA SF3B1 DST ATAD3A AASS SYNE2 EIF2B5 PANK4 NUP133 TRAPPC4 HADHA SNRPD1 XRCC6 HSP90AA1 SLC27A2	3.10e-07	1440	176	24	30833792
Pubmed	ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication.	ATP6AP1 ATP7B LEMD3 RPS3 PPFIBP1 GOSR1 SREBF2 EPB41L3 LDHA LDHB PDIA3 SLC38A1 NEO1 ANO6 NUP133 HADHA POMK HSPA9 HSP90AA1	4.17e-07	952	176	19	38569033
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	CUL3 SLC25A24 SMARCA5 MYH10 SAMD9 RPS3 PPFIBP1 LDHA LDHB NDUFS2 ITPR3 TGM2 SF3B1 DST ATAD3A NUP133 ANKRD17 HADHA SNRPD1 HSPA9 XRCC6 HSP90AA1	4.48e-07	1257	176	22	36526897
Pubmed	Identification of interaction partners for individual SH3 domains of Fas ligand associated members of the PCH protein family in T lymphocytes.	ATAD3A ITSN2 XRCC6 PACSIN2 APBB1IP	4.79e-07	31	176	5	19041431
Pubmed	Protective effect of glutathione in HIV-1 lytic peptide 1-induced cell death in human neuronal cells.	LDHA LDHB LDHC	5.08e-07	4	176	3	11582518
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	5.08e-07	4	176	3	22984479
Pubmed	Direct role of plasma membrane-expressed gp120/41 in toxicity to human astrocytes induced by HIV-1-infected macrophages.	LDHA LDHB LDHC	5.08e-07	4	176	3	11125887
Pubmed	Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.	MYH10 RPS3 LDHA LDHB DST HADHA HSPA9 XRCC6 HSP90AA1	6.20e-07	191	176	9	33762435
Pubmed	Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.	SLC25A24 MYH10 RPS3 EPB41L3 LDHA LDHB SF3B1 ATAD3A SNRPD1 HSPA9 XRCC6 HSP90AA1	6.67e-07	383	176	12	29331416
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	SMARCA5 RPS3 NDUFS2 SF3B1 HADHA HSPA9 XRCC6 HSP90AA1	7.68e-07	144	176	8	35681168
Pubmed	DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis.	LDHA LDHB UHMK1 HSPA9 HSP90AA1	9.00e-07	35	176	5	25458010
Pubmed	Chemical Crosslinking Mass Spectrometry Analysis of Protein Conformations and Supercomplexes in Heart Tissue.	RPS3 OBSCN LDHB PDIA3 NDUFS2 MMAA TGM2 DST ATAD3A HADHA HSPA9	1.11e-06	331	176	11	29199018
Pubmed	Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat.	LDHA LDHB HSP90AA1	1.26e-06	5	176	3	15710247
Pubmed	A human MAP kinase interactome.	MYH10 RIPK1 MYO9A TOM1L1 SREBF2 PAK6 EPB41L3 SF3B1 DST ITSN2 ANKRD17 PACSIN2 HSP90AA1	1.33e-06	486	176	13	20936779
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	SMARCA5 MYH10 MYO9A RPS3 EPB41L3 LDHA LDHB PDIA3 TGM2 USP5 NAA35 SF3B1 DST ATAD3A EIF2B5 NUP133 ANKRD17 HADHA SNRPD1 HSPA9 XRCC6 HSP90AA1	1.51e-06	1353	176	22	29467282
Pubmed	Interactome analysis reveals that lncRNA HULC promotes aerobic glycolysis through LDHA and PKM2.	PPFIBP1 LDHA LDHB PDIA3 EDEM3 TGM2 HSPA9 XRCC6	1.78e-06	161	176	8	32572027
Pubmed	CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer.	MYH10 RPS3 LDHA LDHB ATAD3A HADHA POTEJ HSPA9 XRCC6 HSP90AA1	2.35e-06	288	176	10	31501420
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CDK12 PPFIBP1 ADGRB3 ADGRV1 DST TBC1D1 SYNE2 DOP1B NIN	2.41e-06	225	176	9	12168954
Pubmed	Evaluation of multiple serum markers in advanced melanoma.	LDHA LDHB LDHC	2.52e-06	6	176	3	21858537
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	2.62e-06	119	176	7	28625976
Pubmed	SERBP1 Promotes Stress Granule Clearance by Regulating 26S Proteasome Activity and G3BP1 Ubiquitination and Protects Male Germ Cells from Thermostimuli Damage.	SLC25A24 CDK12 RPS3 STARD7 EPB41L3 LDHA LDHB PDIA3 LDHC USP5 SF3B1 MAPK12 ATAD3A HADHA HSPA9 XRCC6 HSP90AA1	2.63e-06	878	176	17	37223481
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	SMARCA5 MYH10 RPS3 PPFIBP1 STARD7 LDHA LDHB PDIA3 NDUFS2 ORC4 USP5 SF3B1 ATAD3A DNAJA4 SYNE2 UBA6 HADHA PC SNRPD1 HSPA9 XRCC6 HSP90AA1	3.11e-06	1415	176	22	28515276
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	SLC25A24 SMARCA5 MYH10 RPS3 VPS13C EPB41L3 LDHA LDHB PDIA3 NDUFS2 SLC38A1 THADA SF3B1 ATAD3A EIF2B5 NUP133 UBA6 HADHA PC SNRPD1 HSPA9 XRCC6	3.49e-06	1425	176	22	30948266
Pubmed	Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.	LEMD3 RPS3 EPB41L3 PDIA3 ITPR3 COLEC12 SF3B1 ANO6 SYNE2 EIF2B5 NUP133	3.71e-06	375	176	11	32788342
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	MYH10 RPS3 GOSR1 EPB41L3 LDHA LDHB LDHC NDUFS2 USP5 DST PC HSPA9 PACSIN2 HSP90AA1	3.78e-06	621	176	14	22794259
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	SLC25A24 MYH10 RPS3 LDHA PDIA3 EPG5 TGM2 USP5 NAA35 DST ZFHX3 HADHA PC SNRPD1 XRCC6 HSP90AA1	3.90e-06	807	176	16	30575818
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	MYH10 CHMP1B RPS3 PPFIBP1 PDIA3 ZAP70 ITPR3 TGM2 ATAD3A ITSN2 HADHA HSPA9 XRCC6 HSP90AA1	4.14e-06	626	176	14	33644029
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	SMARCA5 EPB41L3 SF3B1 NUP133 HADHA XRCC6 PACSIN2	4.26e-06	128	176	7	23858473
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L7 USP17L4 USP17L1 USP17L3 USP17L8	4.50e-06	48	176	5	16421571
Pubmed	Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.	RPS3 LDHA LDHB PDIA3 PRKD1 XRCC6	4.52e-06	84	176	6	19135240
Pubmed	PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.	MYH10 RPS3 LDHA LDHB SF3B1 DST ATRIP ATAD3A HADHA HSPA9 XRCC6 HSP90AA1	6.38e-06	477	176	12	31300519
Pubmed	O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma.	CUL3 CDK12 LDHA ORC4 SF3B1 HADHA SNRPD1 HSP90AA1 SLC27A2	6.45e-06	254	176	9	36604567
Pubmed	Proteomic characterization of chromosomal common fragile site (CFS)-associated proteins uncovers ATRX as a regulator of CFS stability.	SMARCA5 ABCA13 RPS3 LDHA LDHB PDIA3 NDUFS2 ITPR3 SF3B1 ATAD3A SNRPD1 HSPA9 XRCC6 HSP90AA1	6.57e-06	652	176	14	31180492
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SMARCA5 MYH10 EPB41L3 ITPR3 USP5 SF3B1 DST ATAD3A SYNE2 NUP133 ANKRD17 HADHA HSPA9 XRCC6	6.69e-06	653	176	14	22586326
Pubmed	An Interaction Landscape of Ubiquitin Signaling.	CUL3 PMS2 RPS3 TOM1L1 ITPR3 CUL5 USP5 DST ITSN2 UBA6 XRCC6 SLC27A2	6.94e-06	481	176	12	28190767
Pubmed	Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation.	RPS3 NFS1 LDHA SF3B1 PRKD1 HADHA HSPA9 XRCC6 HSP90AA1	7.31e-06	258	176	9	21081666
Pubmed	RAB-like 2 has an essential role in male fertility, sperm intra-flagellar transport, and tail assembly.	CUL3 LDHC CUL5 USP5 SHCBP1L HSP90AA1	7.67e-06	92	176	6	23055941
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	MYH10 RPS3 EPB41L3 LDHA LDHB POTEJ PC SNRPD1 XRCC6 HSP90AA1	7.79e-06	330	176	10	32529326
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	ATP6AP1 ATP7B LEMD3 GOSR1 TOM1L1 TCIRG1 PDIA3 NDUFS2 ORC4 THADA NEO1 ANO6 NR5A2 DPY19L4 PC DOCK6 FAM8A1 HSPA9	8.17e-06	1061	176	18	33845483
Pubmed	Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3.	SMARCA5 RPS3 TCIRG1 LDHA LDHB PDIA3 ZFHX3 HSPA9 XRCC6 HSP90AA1	8.21e-06	332	176	10	30595499
Pubmed	Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.	CUL3 MYH10 RPS3 EPB41L3 LDHA LDHB ORC4 ANKRD17 PRKD1 HSPA9 HSP90AA1	8.80e-06	411	176	11	36652389
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	PMS2 LURAP1 ANK2 KALRN PPFIBP1 ADGRB3 KRIT1 FN3K SF3B1 DST ZNF532 FMN2 TNKS PC ST18 SNTA1 HSPA9 XRCC6 HSP90AA1 DOP1B	8.91e-06	1285	176	20	35914814
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	UBR2 SMARCA5 MYH10 RPS3 LDHA LDHB SF3B1 DNAJA4 NUP133 HSPA9 XRCC6 HSP90AA1	9.07e-06	494	176	12	26831064
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ANK2 KALRN OBSCN NEO1 DST SYNE2 NUP133 CDK5RAP2 TNKS HSPA9 XRCC6 HSP90AA1	9.63e-06	497	176	12	23414517
Pubmed	Identification of proteins interacting with the mitochondrial small heat shock protein Hsp22 of Drosophila melanogaster: Implication in mitochondrial homeostasis.	SLC25A24 RPS3 NDUFS2 TGM2 HADHA PC HSPA9	1.01e-05	146	176	7	29509794
Pubmed	RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes.	RPS3 LDHA RUFY1 LDHB ATAD3A HADHA PC HSPA9 XRCC6 HSP90AA1	1.12e-05	344	176	10	36282215
Pubmed	Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.	CDK12 ZAP70 TRAPPC4 POMK HSPA9	1.26e-05	59	176	5	31551363
Pubmed	Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia.	PDE4B ANK2 KALRN COLEC12 DST TNKS WWC1	1.26e-05	151	176	7	17043677
Interaction	YWHAQ interactions	CHMP4C CUL3 PDE4B MYO9A RPS3 PPFIBP1 PAK6 EPB41L3 LDHA RUFY1 LDHB TGM2 MIS12 DST AASS TBC1D1 ANKRD17 PRKD1 HADHA CDK11B PC SNRPD1 WWC1 HSP90AA1 SLC27A2 ARHGAP19	1.75e-06	1118	167	26	int:YWHAQ
Interaction	LDHA interactions	CHMP4C CUL3 MYH10 ANK2 LDHA RUFY1 LDHB PDIA3 LDHC CUL5 DST HSPA9 XRCC6 HSP90AA1	3.07e-06	375	167	14	int:LDHA
Interaction	ARL10 interactions	LEMD3 RPS3 PPFIBP1 VPS13C TEX9 LDHA S1PR1 THADA PC HSP90AA1	4.10e-06	189	167	10	int:ARL10
Interaction	HSP90AA2P interactions	CHMP4C CUL3 RUFY1 CUL5 HSPA9 HSP90AA1	6.13e-06	55	167	6	int:HSP90AA2P
Interaction	COPB1 interactions	CUL3 PMS2 RUFY1 PDIA3 EDEM3 SF3B1 ATAD3A PC POMK SNTA1 XRCC6 FOXP3	6.52e-06	294	167	12	int:COPB1
Interaction	TRAP1 interactions	CHMP4C CUL3 RPS3 NFS1 RUFY1 PDIA3 NDUFS2 CUL5 EDEM3 SF3B1 ATAD3A AASS PRKD1 HADHA HSPA9	8.58e-06	468	167	15	int:TRAP1
Interaction	XRCC6 interactions	CHMP4C CUL3 SMARCA5 MYH10 RASA1 CDK12 PPARG LDHA RUFY1 LDHB PDIA3 CUL5 ORC4 SF3B1 ZFHX3 TNKS CDK11B SNRPD1 SNTA1 HSPA9 XRCC6 HSP90AA1	8.87e-06	928	167	22	int:XRCC6
Interaction	NGB interactions	MYH10 RUFY1 LDHB PDIA3 CNTNAP4 HADHA SNRPD1 HSPA9 XRCC6	8.92e-06	163	167	9	int:NGB
Interaction	DNAJA1 interactions	CHMP4C CUL3 MYH10 PPARG RUFY1 LDHB PDIA3 CUL5 THADA MIS12 DNAJA4 PANK4 CDK5RAP2 HSPA9 EDRF1 HSP90AA1	9.66e-06	533	167	16	int:DNAJA1
Interaction	BTF3 interactions	CUL3 MYH10 ATP6AP1 ANK2 CHMP1B RPS3 PPFIBP1 PDIA3 ZAP70 ITPR3 TGM2 NAA35 SF3B1 ATAD3A ITSN2 NUP133 HADHA HSPA9 XRCC6 HSP90AA1	1.07e-05	799	167	20	int:BTF3
Interaction	KCNA3 interactions	ADCY10 ANK2 RIPK1 MYO9A ABCA13 RPS3 PPFIBP1 ICE2 EPB41L3 NDUFS2 SLC38A1 DST ATAD3A UBA6 ANKRD17 CDK5RAP2 HADHA HSPA9 XRCC6 PACSIN2 HSP90AA1	1.12e-05	871	167	21	int:KCNA3
Interaction	RAB40A interactions	RAB40A CUL5 RAB40AL HSP90AA1	1.60e-05	19	167	4	int:RAB40A
Interaction	NPEPPS interactions	CHMP4C CUL3 LDHA RUFY1 LDHB PDIA3 TGM2 UBA6 XRCC6	1.73e-05	177	167	9	int:NPEPPS
Interaction	PRKDC interactions	CHMP4C CUL3 PMS2 SMARCA5 RUFY1 CUL5 USP5 THADA SF3B1 ATRIP SYNE2 UBA6 CDK5RAP2 POLL POMK SNRPD1 XRCC6 HSP90AA1	1.95e-05	695	167	18	int:PRKDC
Interaction	RAB4A interactions	ATP7B LEMD3 RPS3 VPS13C LDHA RUFY1 LDHB ITPR3 SLC38A1 COLEC12 DST ANO6 SYNE2 DOP1B	2.85e-05	457	167	14	int:RAB4A
Interaction	ATG16L1 interactions	SMARCA5 LEMD3 CDK12 RPS3 VPS13C CCDC168 TEX9 LDHA RUFY1 LDHB PDIA3 ITPR3 COLEC12 USP5 THADA ATRIP TBC1D1 ITSN2 EIF2B5 CDK5RAP2 TAF5 HSPA9 XRCC6 HSP90AA1	3.21e-05	1161	167	24	int:ATG16L1
Interaction	CAV1 interactions	CUL3 PPFIBP1 GOSR1 TOM1L1 PPARG EPB41L3 RUFY1 PDIA3 S1PR1 ADCY5 ITPR3 SLC38A1 USP5 NEO1 DST FMN2 PACSIN2 HSP90AA1	3.33e-05	724	167	18	int:CAV1
Interaction	YWHAG interactions	CHMP4C CUL3 MYH10 MYO9A CDK12 PPFIBP1 PPARG PAK6 EPB41L3 LDHB TGM2 MIS12 DST AASS TBC1D1 SYNE2 FMN2 ANKRD17 PRKD1 CDK11B HSPA9 EDRF1 WWC1 HSP90AA1 ARHGAP19	3.63e-05	1248	167	25	int:YWHAG
Interaction	YWHAE interactions	CHMP4C CUL3 UBR2 MYH10 MYO9A CDK12 RPS3 PPFIBP1 PAK6 EPB41L3 RUFY1 LDHB MIS12 SF3B1 DST AASS TBC1D1 ANKRD17 PRKD1 CDK11B SNRPD1 WWC1 HSP90AA1 ARHGAP19 NIN	4.03e-05	1256	167	25	int:YWHAE
Interaction	FGD5 interactions	MYH10 RPS3 LDHA LDHB DST HADHA HSPA9 XRCC6 HSP90AA1	5.90e-05	207	167	9	int:FGD5
Interaction	CHMP4C interactions	CHMP4C SMARCA5 MYH10 MYO9A CHMP1B LDHA LDHB PDIA3 ITPR3 SF3B1 ATAD3A NUP133 CNTNAP4 SNRPD1 HSPA9 XRCC6 HSP90AA1	5.91e-05	687	167	17	int:CHMP4C
Interaction	HULC interactions	PPFIBP1 LDHA LDHB PDIA3 EDEM3 TGM2 HSPA9 XRCC6	6.03e-05	161	167	8	int:HULC
Interaction	YWHAZ interactions	CHMP4C CUL3 MYH10 MYO9A PPFIBP1 PAK6 EPB41L3 RUFY1 LDHB TGM2 MIS12 SF3B1 DST AASS TBC1D1 SYNE2 ANKRD17 CDK5RAP2 PRKD1 CDK11B HSPA9 XRCC6 HSP90AA1 ARHGAP19 NIN	8.87e-05	1319	167	25	int:YWHAZ
Interaction	UBE2M interactions	CUL3 MYH10 RPS3 ADGRV1 LDHA LDHB PDIA3 CUL5 MIS12 UHMK1 HADHA SNRPD1 HSPA9 XRCC6 HSP90AA1 FOXP3	1.06e-04	651	167	16	int:UBE2M
Interaction	TUBGCP2 interactions	CUL3 RPS3 RUFY1 ATAD3A CDK5RAP2 HSPA9 NIN FOXP3	1.12e-04	176	167	8	int:TUBGCP2
Interaction	HSPA9 interactions	CHMP4C CUL3 RASA1 PPARG LDHA RUFY1 LDHB PDIA3 NDUFS2 ITPR3 CUL5 TGM2 DNAJA4 HADHA HSPA9 XRCC6 HSP90AA1	1.17e-04	727	167	17	int:HSPA9
Interaction	TRIM24 interactions	CUL3 LURAP1 MYH10 CDK12 RPS3 PPARG PDIA3 SF3B1 ATAD3A FMN2 ANKRD17 XRCC6	1.25e-04	398	167	12	int:TRIM24
Interaction	PGD interactions	CHMP4C RASA1 PPARG PAK6 LDHA LDHB PDIA3 TGM2	1.26e-04	179	167	8	int:PGD
Interaction	EFTUD2 interactions	CHMP4C CUL3 SMARCA5 MYH10 RPS3 PPFIBP1 STARD7 PPARG LDHA RUFY1 LDHB PDIA3 NDUFS2 CUL5 ORC4 USP5 SF3B1 ATAD3A DNAJA4 SYNE2 HADHA PC SNRPD1 HSPA9 XRCC6 HSP90AA1	1.53e-04	1449	167	26	int:EFTUD2
Interaction	SPSB1 interactions	RASA1 CUL5 ATRIP HSP90AA1	1.54e-04	33	167	4	int:SPSB1
Interaction	AGO2 interactions	CUL3 MYH10 RPS3 PPARG NDUFS2 KRIT1 CUL5 NAA35 DNAJA4 TBC1D1 ANKRD17 XRCC6 HSP90AA1	1.61e-04	472	167	13	int:AGO2
Interaction	RAB11A interactions	MYH10 LEMD3 CHMP1B PPFIBP1 VPS13C RUFY1 KRIT1 ITPR3 SLC38A1 COLEC12 DST ANO6 TBC1D1 SYNE2 NUP133 HADHA PACSIN2 DOP1B	1.88e-04	830	167	18	int:RAB11A
Interaction	SNAI1 interactions	SLC25A24 MYH10 USP17L2 RPS3 EPB41L3 LDHA LDHB SF3B1 ATAD3A PRKD1 SNRPD1 HSPA9 XRCC6 HSP90AA1	1.89e-04	546	167	14	int:SNAI1
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.22e-18	79	176	13	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	4.40e-12	222	176	13	chr4p16
Cytoband	8p23.1	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 TNKS USP17L8	2.39e-06	154	176	7	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L7 USP17L4 USP17L2 USP17L1 USP17L3 TNKS USP17L8	3.62e-05	234	176	7	chr8p23
Coexpression	GERY_CEBP_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 TOM1L1 USP17L5 USP17L19 PPARG USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 WWC1 APBB1IP USP17L8 USP17L13	7.57e-23	160	173	22	MM1155
Coexpression	MADAN_DPPA4_TARGETS	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	2.37e-22	86	173	18	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	3.80e-20	112	173	18	MM1095
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L7 CHMP4C USP17L21 USP17L4 MYH10 PDE4B USP17L2 USP17L12 USP17L1 USP17L20 CHMP1B USP17L11 USP17L5 USP17L19 NFS1 TEX9 RUFY1 KRIT1 EPG5 USP17L18 COLEC12 USP17L17 DNAJA4 TBC1D1 UHMK1 USP17L6P USP17L3 USP17L22 SNRPD1 USP17L15 PACSIN2 USP17L8 USP17L13	2.58e-12	1198	173	33	MM1062
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 USP17L18 TGM2 NAA35 USP17L17 USP17L6P USP17L3 ANKRD17 FAM216A USP17L22 USP17L15 USP17L8 DOP1B USP17L13	5.65e-11	647	173	23	MM981
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 CHMP1B USP17L11 TCIRG1 USP17L5 USP17L19 TEX9 ZAP70 USP17L18 TGM2 NAA35 USP17L17 TBC1D1 UHMK1 USP17L6P USP17L3 ANKRD17 FAM216A USP17L22 FAM8A1 USP17L15 USP17L8 DOP1B USP17L13	5.08e-10	1226	173	30	MM979
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L7 CUL3 SLC25A24 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L19 PDIA3 ZAP70 USP17L18 USP17L17 USP17L6P USP17L3 FAM216A HADHA USP17L22 USP17L15 APBB1IP USP17L8 USP17L13	4.27e-08	1072	173	25	MM1031
Coexpression	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP	CUL3 UBR2 SMARCA5 ANK2 GOSR1 TOM1L1 S1PR1 TFAP2B SLC38A1 DST SYNE2 ANKRD17	2.94e-06	340	173	12	M2012
Coexpression	PARENT_MTOR_SIGNALING_UP	PMS2 SAMD9 CDK12 CHMP1B VPS13C SREBF2 THADA DNAJA4 SYNE2 EIF2B5 PANK4 PRKD1 HADHA DOCK6 TTC38	5.84e-06	567	173	15	M16909
Coexpression	SHEN_SMARCA2_TARGETS_UP	UBR2 SMARCA5 RASA1 VPS13C KRIT1 CUL5 ORC4 ITSN2 NUP133 TRAPPC4 ANKRD17 PRKD1	3.01e-05	429	173	12	M29
Coexpression	MOOTHA_GLUCONEOGENESIS	LDHA LDHB LDHC PC	5.02e-05	31	173	4	M13448
Coexpression	GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	UBR2 SAMD9 RASA1 VPS13C NFS1 FAM8A1 APBB1IP ARHGAP19	5.18e-05	197	173	8	M5351
Coexpression	GSE15330_HSC_VS_PRO_BCELL_DN	PMS2 STARD7 LDHA NDUFS2 TBC1D1 FAM216A PC XRCC6	5.76e-05	200	173	8	M7063
Coexpression	LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA	SMARCA5 MYH10 LDHA LDHB PDIA3 SLC38A1 SF3B1 HADHA HSPA9 HSP90AA1	5.92e-05	322	173	10	M39237
Coexpression	NEBEN_AML_WITH_FLT3_OR_NRAS_DN	CYP2J2 RPS3 LDHB	5.95e-05	12	173	3	M12530
Coexpression	LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA	RPS3 LDHA LDHB PDIA3 CUL5 SLC38A1 SF3B1 HADHA HSPA9 HSP90AA1	6.56e-05	326	173	10	M39238
Coexpression	LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB	ANK2 RPS3 VPS13C LDHA LDHB PDIA3 TGM2 SF3B1 HSP90AA1	7.69e-05	268	173	9	M39228
Coexpression	LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB	MYO9A LDHA LDHB PDIA3 SLC38A1 TGM2 SF3B1 HSPA9 HSP90AA1	1.02e-04	278	173	9	M39227
Coexpression	LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB	VPS13C LDHA LDHB PDIA3 TGM2 SF3B1 PRKD1 HADHA HSPA9 HSP90AA1	1.26e-04	353	173	10	M39229
Coexpression	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	MYH10 LDHA LDHB PDIA3 NDUFS2 SLC38A1 AASS EIF2B5 HADHA HSPA9 XRCC6 HSP90AA1 SLC27A2 ARHGAP19	1.51e-04	669	173	14	M18635
ToppCell	VE-CD4-CD4_Treg\|VE / Condition, Cell_class and T cell subcluster	TOM1L1 LDHB S1PR1 SYNE2 DPY19L4 TRAV34 FOXP3	6.33e-07	129	169	7	e89d414e1b23e1656747defa39f09b51944a2166
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	CUL3 PDE4B S1PR1 ZAP70 SLC38A1 THADA SYNE2 NIN	6.82e-07	190	169	8	91ba66d4b56c59523485b17738e93f14bb00afa4
ToppCell	COVID-19_Severe-Lymphoid_T/NK-gd_T\|COVID-19_Severe / Disease group, lineage and cell class	S1PR1 ZAP70 SLC38A1 GFY FHAD1 SYNE2 UHMK1 TTC38	8.29e-07	195	169	8	9990440bda7fac5d00ef80444fab07459be625e1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	S1PR1 ZAP70 SLC38A1 GFY FHAD1 SYNE2 UHMK1 TTC38	8.62e-07	196	169	8	418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	S1PR1 ZAP70 SLC38A1 GFY FHAD1 SYNE2 UHMK1 TTC38	8.62e-07	196	169	8	6beaf0c2799424c59819b286fbb5c1a83d85e4d1
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A EPB41L3 COLEC12 ZNF532 ANO6 ST18 ARHGAP19	3.03e-06	163	169	7	8dc0128eeede933537e3bcc5d6ec0322711552f3
ToppCell	droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A EPB41L3 COLEC12 ZNF532 ANO6 ST18 ARHGAP19	3.03e-06	163	169	7	fd243ca223079033be480a24817a399f281fa4d4
ToppCell	Ionocyte-iono-1\|World / Class top	PPARG LDHB ADCY5 COLEC12 PZP EDRF1 SLC27A2	3.85e-06	169	169	7	4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c
ToppCell	Ionocyte\|World / Class top	PPARG LDHB ADCY5 COLEC12 FMN2 APBB1IP SLC27A2	4.00e-06	170	169	7	d2e592f2a679e6a8d32f2b752d9a3c493e50ced4
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-nan\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC25A24 STARD7 PPARG EPB41L3 CYP39A1 LDHB TGM2	5.03e-06	176	169	7	1dd54bfaa58541de51e5a8328651d390833bd480
ToppCell	droplet-Limb_Muscle-MUSCLE-30m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA5 CDK12 VPS13C SYNE2 ITSN2 TNKS HSP90AA1	5.42e-06	178	169	7	01dafd19de04eff459253eaa9a35debf8f3deedf
ToppCell	3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 KALRN PPFIBP1 S1PR1 KLHL3 DST DOCK6	5.42e-06	178	169	7	ad3de3e03a401dac64431a541899445262246347
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 MYO9A ABCA13 PPFIBP1 ADGRV1 ADCY5 WWC1	6.27e-06	182	169	7	eb138aa1dca9373f1586600f258df06dcf56d81f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN ABCA13 MROH2A OBSCN ADGRV1 CNTNAP4 ST18	6.73e-06	184	169	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN ABCA13 MROH2A OBSCN ADGRV1 CNTNAP4 ST18	6.73e-06	184	169	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KALRN ABCA13 MROH2A OBSCN ADGRV1 CNTNAP4 ST18	6.73e-06	184	169	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-Heart-CM_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK2 CYP2J2 OBSCN SYNDIG1 ADCY5 ANKRD2 UGT2B4	6.73e-06	184	169	7	e737f0f14c49b07bbb04a165083ac32210bc5690
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 MYO9A ABCA13 PPFIBP1 ADGRV1 DNAH17 WWC1	7.48e-06	187	169	7	c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 ADGRV1 ADCY5 SYNE2 PRKD1 WWC1	7.75e-06	188	169	7	af740fa78542438fdff627ea1f74f4eee43316be
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA5 VPS13C STARD7 CUL5 ATAD3A NR5A2 HSPA9	8.30e-06	190	169	7	36e83995021ba16690f84e2077a9e8baec547d05
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMARCA5 VPS13C STARD7 CUL5 ATAD3A NR5A2 HSPA9	8.30e-06	190	169	7	d26be9e1b676f750e716b91ebc3598fac3735612
ToppCell	CD8+_Memory_T_cell-CV-7\|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster	UBR2 VPS13C PDIA3 SLC38A1 EDRF1 SLC27A2 DOP1B	8.59e-06	191	169	7	9454f642c3621370fa23640b631301346b300950
ToppCell	COVID_non-vent-Lymphocytic-T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	RPS3 OBSCN LDHB S1PR1 ZAP70 SLC38A1 SYNE2	9.83e-06	195	169	7	4bdedd924564a260841a9153604026b57487c83d
ToppCell	COVID-19-kidney-TAL\|kidney / Disease (COVID-19 only), tissue and cell type	MYO9A ADGRV1 TFAP2B ITPR3 DST ZNF532 PRKD1	1.02e-05	196	169	7	04f5eb206ed3016a737609a3ebac0c1fcabb94ef
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	S1PR1 ZAP70 SLC38A1 GFY FHAD1 SYNE2 TTC38	1.02e-05	196	169	7	581fc8c8d42005aacd7b401a2c9d1fc331fb4af7
ToppCell	PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	S1PR1 ZAP70 SLC38A1 GFY FHAD1 SYNE2 TTC38	1.02e-05	196	169	7	c35f2349dfe35baa845f790b9f31673dceac54c0
ToppCell	Severe-Lymphoid-T-CCR7+_T\|Severe / Condition, Lineage, Cell class and cell subclass	PDE4B RPS3 LDHB S1PR1 ZAP70 SLC38A1 SYNE2	1.05e-05	197	169	7	0489e0b08f3c3ef90b166ea2f26a0b2b12bd2077
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE4B SAMD9 RPS3 S1PR1 ZAP70 SLC38A1 SYNE2	1.05e-05	197	169	7	0b4fdf0131dd67a86ee3209fa66db0ca2e01a10e
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE4B SAMD9 RPS3 S1PR1 ZAP70 SLC38A1 SYNE2	1.05e-05	197	169	7	b3876076684781fb8384117f2cf367d828985986
ToppCell	(10)_Ciliated-(2)_GFP_FOXI1\|(10)_Ciliated / shred by cell type by condition	SAMD9 VPS13C TEX9 FHAD1 SYNE2 HSP90AA1 SLC27A2	1.12e-05	199	169	7	61b1ed2db71b96157b92b7535d1955a4033098da
ToppCell	COVID-19-COVID-19_Severe-Others-HSPC\|COVID-19_Severe / Disease, condition lineage and cell class	MYH10 PPFIBP1 DST MAPK12 SHF FAM216A SLC27A2	1.12e-05	199	169	7	25de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCell	healthy_donor-Lymphocytic\|healthy_donor / Disease condition, Lineage, Cell class and subclass	RPS3 LDHB S1PR1 ZAP70 SLC38A1 SYNE2 TTC38	1.12e-05	199	169	7	2841e16d54acd344ba454f024e285c28abc37319
ToppCell	myeloid-Dendritic_cell-Conventional_dendritic_cell\|myeloid / Lineage, cell class and subclass	LDHA LDHB PDIA3 SLC38A1 HADHA HSPA9 HSP90AA1	1.12e-05	199	169	7	1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH10 ANK2 COLEC12 TGM2 DST PRKD1 PZP	1.12e-05	199	169	7	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	myeloid-Dendritic_cell\|myeloid / Lineage, cell class and subclass	LDHA LDHB PDIA3 SLC38A1 HADHA HSPA9 HSP90AA1	1.12e-05	199	169	7	b81c0a40481f1006ac4aa8759af95448cb5fc2e6
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 ANK2 COLEC12 TGM2 DST PRKD1 PZP	1.16e-05	200	169	7	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 ANK2 COLEC12 TGM2 DST PRKD1 PZP	1.16e-05	200	169	7	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	PDE4B S1PR1 TGM2 DST SYNE2 NR5A2 DOCK6	1.16e-05	200	169	7	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	UBR2 SMARCA5 SAMD9 VPS13C SF3B1 SYNE2 ITSN2	1.16e-05	200	169	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated\|COVID-19_Mild / Disease, condition lineage and cell class	SAMD9 OBSCN LDHB SLC38A1 KLHL3 DST SYNE2	1.16e-05	200	169	7	d9e8a0d047d4403fb7265fde7448e23a7780785c
ToppCell	COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T\|COVID-19_Severe / Disease, condition lineage and cell class	S1PR1 ZAP70 SLC38A1 FHAD1 SYNE2 UHMK1 TTC38	1.16e-05	200	169	7	f72bc3f6606ae77fe1b0a972e35b3ce0727804d9
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	PDE4B S1PR1 TGM2 DST SYNE2 NR5A2 DOCK6	1.16e-05	200	169	7	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	MS-CD4-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	ADCY10 SAMD9 LDHB SLC38A1 SYNE2 NR5A2	2.53e-05	152	169	6	b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GRIK2 SCGN FNDC11 FMN2 POTEJ ST18	3.26e-05	159	169	6	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	356C-Fibroblasts-Fibroblast-G-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KIF6 ATP7B ADGRB3 S1PR1 TGM2 DST	3.38e-05	160	169	6	0293b244c063a62819690bf22bbc2681f8d15252
ToppCell	356C-Fibroblasts-Fibroblast-G\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	KIF6 ATP7B ADGRB3 S1PR1 TGM2 DST	3.38e-05	160	169	6	3eaae86fa08f7651021316f8e5811bf48055591e
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VPS13C CYP39A1 LDHB CUL5 NR5A2 ZFHX3	4.44e-05	168	169	6	d69452e2cfeb74023b5cf3d09064d7dcad0008ec
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ANK2 GRIK2 SCGN FMN2 POTEJ ST18	4.59e-05	169	169	6	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	Ionocyte-iono-2\|World / Class top	PPARG LDHB ADCY5 COLEC12 FMN2 SLC27A2	5.22e-05	173	169	6	e5ec28ccc5e048fd98de4c876e5c53b866b66228
ToppCell	facs-Marrow-B-cells-24m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RPS3 ADGRB3 GRIK2 ADGRV1 SCGN CNTNAP4	5.57e-05	175	169	6	887e75fc90e59a6394d62f3c048a9cfdf6707725
ToppCell	droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A ANO6 TBC1D1 DNAH17 UBA6 ST18	5.93e-05	177	169	6	14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 EPB41L3 SYNE2 PC TTC38 SLC27A2	6.51e-05	180	169	6	f8bdfd7bf7b3d52c659a29d8f5f80858e79da83e
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	KALRN ADGRB3 PPARG SCGN DENND3 PACSIN2	6.71e-05	181	169	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	droplet-Kidney-nan-3m-Hematologic-nan\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR1 ZAP70 THADA POLL APBB1IP NIN	6.71e-05	181	169	6	58d7e76dfaa818aeaef7f129c4472bf5b6563218
ToppCell	droplet-Kidney-nan-3m-Hematologic\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR1 ZAP70 THADA POLL APBB1IP NIN	6.71e-05	181	169	6	5d76e99bf2b5b337041efd3cd33bebbb0637b64e
ToppCell	10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MYH10 RPS3 LDHB FAM216A SNRPD1 SLC27A2	6.71e-05	181	169	6	ee207ea171e2ffc22a7f850be57bb118a87e0f81
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 MYO9A ABCA13 PPFIBP1 ADGRV1 WWC1	6.71e-05	181	169	6	9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9
ToppCell	droplet-Kidney-nan-3m-Hematologic-leukocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	S1PR1 ZAP70 THADA POLL APBB1IP NIN	6.71e-05	181	169	6	970fc90e27236ee30190f1a02f418a378919c60b
ToppCell	RA-07._Pericyte\|World / Chamber and Cluster_Paper	KALRN ADGRB3 PPARG SCGN DENND3 PACSIN2	6.92e-05	182	169	6	2075efeae633550fb2eb026d0dfd741c8252482e
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	ANK2 GRIK2 SCGN FMN2 POTEJ ST18	6.92e-05	182	169	6	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	Control-Epithelial_cells-Airway_ciliated\|Control / group, cell type (main and fine annotations)	KIF6 ABCA13 FHAD1 FMN2 CFAP206 CFAP74	6.92e-05	182	169	6	fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175\|Adult / Lineage, Cell type, age group and donor	KALRN PPFIBP1 SCGN LGR5 S1PR1 DOCK6	6.92e-05	182	169	6	8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac
ToppCell	5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYH10 KALRN PPFIBP1 KLHL3 DST DOCK6	7.13e-05	183	169	6	4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-Bergmann_glial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRB3 SYNDIG1 PPARG SLC38A1 COLEC12 AASS	7.13e-05	183	169	6	99bb4ceb92f6467f2359a42ab2cff6df18825a30
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	SLC25A24 SCRN3 CCDC168 ANO6 NUP133 FOXP3	7.13e-05	183	169	6	3cbe0175d05fd39bc430de1ef471ff2c5b56460e
ToppCell	PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MROH2A ADGRV1 ITPR3 SLC38A1 WWC1 SLC27A2	7.35e-05	184	169	6	fa4915b0498f3069fd5ef497286445528f75187e
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TCIRG1 EPB41L3 LDHA COLEC12 TGM2 UBA6	7.35e-05	184	169	6	e343dd7777a29048e3f12a939f7f782b8b7b4fea
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK2 CYP2J2 OBSCN SYNDIG1 ADCY5 ANKRD2	7.57e-05	185	169	6	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PDE4B KALRN PPFIBP1 PPARG KLHL3 NR5A2	7.57e-05	185	169	6	f9f48251bc33eb6bf2cff580d1a3207d21450aa0
ToppCell	CV-Moderate-7\|Moderate / Virus stimulation, Condition and Cluster	UBR2 VPS13C PDIA3 SLC38A1 SLC27A2 DOP1B	7.57e-05	185	169	6	a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f
ToppCell	LA-07._Pericyte\|LA / Chamber and Cluster_Paper	KALRN ADGRB3 SCGN DENND3 DOCK6 PACSIN2	7.57e-05	185	169	6	ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 LDHB TFAP2B DST SYNE2 CFAP74	7.80e-05	186	169	6	8eafd4bea692f7ef33de27dd53f9d1fe67deaad8
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 ADCY5 SYNE2 PRKD1 WWC1	7.80e-05	186	169	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 ADCY5 SYNE2 PRKD1 WWC1	8.03e-05	187	169	6	c31130fc2f9f882944b2ba366a034a03f051c4b9
ToppCell	droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PPARG CYP39A1 PABPC1L TNKS SNTA1	8.07e-05	116	169	5	f2bf9599040f43b5ea8724841d7b71c0a859c016
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB6 CCDC168 NR5A2 PZP	8.48e-05	61	169	4	12de8c495c7f47ecd720f29a573471705603732a
ToppCell	Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Th-Inhibitory_Neuron.Th.Vcan_(SNc)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCDHGB6 CCDC168 NR5A2 PZP	8.48e-05	61	169	4	a655232c6d92335eb086723ab9b05eb3a5479b68
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ADCY10 OBSCN LDHC PABPC1L	8.48e-05	61	169	4	5e855b5462f42b7a1d0bbd518cc11072342ce0cc
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1-Excitatory_Neuron.Slc17a7.Reln_(Medial_entorrhinal_cortexm,_Reln+/Cbln1+)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ADCY10 OBSCN LDHC PABPC1L	8.48e-05	61	169	4	2fc13475581431f82e0b5ef42e18cd29c9787666
ToppCell	droplet-Thymus-nan-21m-Lymphocytic-nan\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHMP1B LDHB ZAP70 FN3K CFAP74 XRCC6	8.52e-05	189	169	6	a1773ef8fe4518d8f3b17c6fb2c3ff3bbc4d79ad
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_3\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	LEMD3 ITPR3 NAA35 UHMK1 POLL FOXP3	8.52e-05	189	169	6	99b01893da9f9f7c9528afaffad178285211738b
ToppCell	COVID-19_Severe-HSPC\|COVID-19_Severe / disease group, cell group and cell class	MYH10 PPFIBP1 MAPK12 SHF FAM216A SLC27A2	8.52e-05	189	169	6	96015439971e2e5b8d6294ca5a6b873c7774e925
ToppCell	Somatosensory_Cortex_(S1)-Non-neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NKX6-2 CYP2J2 AASS ZFHX3 ST18 APBB1IP	8.52e-05	189	169	6	42ab4cc5fbf8580841f31889446fe4499df1a464
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	ANK2 OBSCN STARD7 SYNDIG1 SLC38A1 ANKRD2	8.52e-05	189	169	6	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 MYO9A ADGRV1 TFAP2B DNAH17 WWC1	8.77e-05	190	169	6	1cf023e3c6924d6a06f353d4b62444b6f2fee8a7
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE4B LDHB ZAP70 SLC38A1 SYNE2 HSP90AA1	8.77e-05	190	169	6	55df73c8b696967a925b1772631f6900eff0fa30
ToppCell	COVID-19-Heart\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ANK2 CYP2J2 KALRN OBSCN ADCY5 ANKRD2	8.77e-05	190	169	6	918ad5037881212008f9f69d5df5da91fd01422c
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZAP70 ADGRG4 SLC38A1 NEO1 SYNE2 PZP	8.77e-05	190	169	6	05e6af222d0ad97cb69f399a96c9038f9dd989b9
ToppCell	ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics\|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	MYH10 PDE4B ANK2 KALRN PPFIBP1 SLC38A1	8.77e-05	190	169	6	9ce301841ce9486701fa28eb2a9929e35d476878
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 TFAP2B ITPR3 PRKD1 WWC1	8.77e-05	190	169	6	3fc9e18c7441c0ae8cda65753cc42d0520f4e116
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK2 MYO9A ADGRV1 TFAP2B DNAH17 WWC1	8.77e-05	190	169	6	59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PDE4B LDHB ZAP70 SLC38A1 SYNE2 HSP90AA1	8.77e-05	190	169	6	494fbab37305a7f92cddec75b291d42282555f5f
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 RPS3 LDHB ZAP70 SLC38A1 SYNE2	8.77e-05	190	169	6	1634a6044dce4e026a63976031a498c7460e3dce
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD7 CYP39A1 LDHB TGM2 ATAD3A HSPA9	8.77e-05	190	169	6	c0ee404d705b0b4f0c6ded4d070ad85eac4b16db
ToppCell	367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|367C / Donor, Lineage, Cell class and subclass (all cells)	RPS3 ZAP70 SLC38A1 SYNE2 TTC38 HSP90AA1	8.77e-05	190	169	6	4240d52a465bc3f8016834b22a35c44ba2b0a9f4
ToppCell	systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_em-female\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	SAMD9 RPS3 LDHB ZAP70 SLC38A1 SYNE2	8.77e-05	190	169	6	08813c2f9321b82f0ec66854bb7a383aa1171780
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYO9A ABCA13 PPFIBP1 SYNE2 PRKD1 WWC1	9.02e-05	191	169	6	d0e9afe7b6334dd515d3e68892efdc76347a55e5
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	CHMP4C KALRN ADCY5 DENND3 TGM2 TBC1D1	9.02e-05	191	169	6	2da83c493e60ad0278848957645277d76737a188
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 ANK2 ADGRB3 CYP39A1 COLEC12 PRKD1	9.29e-05	192	169	6	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE4B SAMD9 RPS3 ZAP70 SLC38A1 APBB1IP	9.29e-05	192	169	6	dceb8b38c2ddb1a848132bd52edc8e883e7d2aa9
Drug	NADP(H	ATP6AP1 CYP26B1 CYP2J2 LDHA CYP39A1 LDHB LDHC NDUFS2 KRIT1 AASS UHMK1 EIF2B5 UGT2B4 HADHA UGT2B28 PC HSP90AA1	1.98e-07	527	160	17	CID000000930
Drug	ox-Q	LDHA LDHB LDHC	1.36e-06	4	160	3	CID000448650
Drug	1,2,4-oxadiazole	ATP6AP1 LDHA LDHB LDHC ZAP70	3.26e-06	33	160	5	CID006451463
Drug	spirobishexahydropyrimidine	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000100750
Drug	AC1O5TJF	LDHA LDHB LDHC	3.37e-06	5	160	3	CID006440410
Drug	1,4-diethoxybutane	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000232578
Drug	C4H3NO4	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000448651
Drug	S-lac-NAD	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000194292
Drug	sorbarin	LDHA LDHB LDHC	3.37e-06	5	160	3	CID009824100
Drug	AC1O5ZB9	LDHA LDHB LDHC	3.37e-06	5	160	3	CID006443605
Drug	AC1L49DG	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000152931
Drug	N-trifluoroacetyl-glycine	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000136227
Drug	acetylphosphonic acid	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000081311
Drug	NSC-60195	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000020481
Drug	ethyl gossypol	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000374353
Drug	oxyayanin A	LDHA LDHB LDHC	3.37e-06	5	160	3	CID005281676
Drug	B-HAD	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000131338
Drug	SQ 31,486	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000130015
Drug	BMS-188107	LDHA LDHB LDHC	3.37e-06	5	160	3	CID000192297
Drug	potassium citrate	LDHA LDHB LDHC PRKD1	4.00e-06	16	160	4	CID000013344
Drug	tripotassium citrate monohydrate	LDHA LDHB LDHC PRKD1	4.00e-06	16	160	4	CID002735208
Drug	S-allyl-L-cysteine	LDHA LDHB LDHC TGM2 POLL	5.09e-06	36	160	5	CID000098280
Drug	Calpain Inhibitor Vi	LDHA LDHB LDHC TRAPPC4	5.21e-06	17	160	4	CID009885817
Drug	bromobenzene	CYP2J2 LDHA CYP39A1 LDHB PDIA3 LDHC AASS	5.61e-06	97	160	7	CID000007961
Drug	oxamate	LDHA LDHB LDHC HADHA PC	6.70e-06	38	160	5	CID000000974
Drug	BL-443	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000054436
Drug	dansyl-L-lysine	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000598797
Drug	I 65	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000149068
Drug	D 701	LDHA LDHB LDHC	6.71e-06	6	160	3	CID003051460
Drug	2,3-dihydroxy-1-naphthoic acid	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000028002
Drug	AC1L24G8	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000066023
Drug	oxymethacil	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000096369
Drug	SQ 32,926	LDHA LDHB LDHC	6.71e-06	6	160	3	CID000131363
Drug	hydride	ATP6AP1 CYP26B1 CYP2J2 TCIRG1 PPARG LDHA CYP39A1 LDHB LDHC NDUFS2 ITPR3 MMAA AASS TRAPPC4 TNKS PRKD1 HADHA EDRF1 SLC27A2	6.81e-06	835	160	19	CID000000783
Drug	AC1Q4V1U	LDHA LDHB LDHC AASS	8.39e-06	19	160	4	CID000090059
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A	SCRN3 GRIK2 PAK6 S1PR1 CUL5 USP5 DNAJA4 POLL TTC38	1.15e-05	198	160	9	2066_UP
Drug	AC1O7170	LDHA LDHB LDHC	1.17e-05	7	160	3	CID006540699
Drug	BS35	LDHA LDHB LDHC	1.17e-05	7	160	3	CID000029316
Drug	BS36	LDHA LDHB LDHC	1.17e-05	7	160	3	CID000029308
Drug	pentabromoacetone	LDHA LDHB LDHC	1.17e-05	7	160	3	CID000065579
Drug	methyl-4-hydroxy-3-nitrobenzimidate	LDHA LDHB LDHC	1.17e-05	7	160	3	CID005492576
Drug	gossylic iminolactone	LDHA LDHB LDHC	1.17e-05	7	160	3	CID005479302
Drug	N-acetyl-9-O-lactylneuraminic acid	LDHA LDHB LDHC	1.17e-05	7	160	3	CID000191486
Drug	sodium glycolate	LDHA LDHB LDHC	1.17e-05	7	160	3	CID000517347
Drug	AC1NSM0G	LDHA LDHB LDHC	1.17e-05	7	160	3	CID005365671
Drug	wartmannin	MYH10 RASA1 MYO9A GOSR1 TOM1L1 PPARG RUFY1 PDIA3 S1PR1 SLC38A1 COLEC12 MAPK12 CDK5RAP2 PRKD1 HADHA TAF5 XRCC6 HSP90AA1	1.69e-05	811	160	18	CID000005691
Drug	p-(phenoxypropoxy)aniline	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000423258
Drug	BS37	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000027925
Drug	U75412E	LDHA LDHB LDHC	1.86e-05	8	160	3	CID003035460
Drug	AC1Q3O0A	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000060880
Drug	UR-12633	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000128030
Drug	2-methyl-2-pentenoate	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000018458
Drug	AC1L4GHU	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000156607
Drug	N-dodecyl morpholine	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000073764
Drug	S-(2-chloroethyl)-L-cysteine	LDHA LDHB LDHC	1.86e-05	8	160	3	CID000034229
Drug	hydroxymalonate	LDHA LDHB LDHC UHMK1	1.87e-05	23	160	4	CID000000044
Drug	fluoropyruvate	LDHA LDHB LDHC PC	1.87e-05	23	160	4	CID000067946
Drug	coenzyme 1	PAK6 LDHA CYP39A1 LDHB PDIA3 LDHC ADCY5 NDUFS2 AASS UHMK1 TNKS HADHA PC XRCC6 SLC27A2	2.12e-05	596	160	15	CID000000925
Drug	thiazolyl blue	TCIRG1 PPARG LDHA LDHB LDHC	2.16e-05	48	160	5	CID000064965
Drug	benzamyl	LDHA LDHB LDHC	2.77e-05	9	160	3	CID000160884
Drug	Bcdfg	LDHA LDHB LDHC	2.77e-05	9	160	3	CID003036106
Drug	N-acetyl-ala-ala-ala-methyl ester	LDHA LDHB LDHC	2.77e-05	9	160	3	CID000100120
Drug	lithocholyltaurine	LDHA LDHB LDHC TGM2 UGT2B4 PRKD1 PACSIN2 HSP90AA1	3.43e-05	175	160	8	CID000010595
Drug	mianserin	ADCY10 LDHA LDHB LDHC ADCY5 PRKD1	3.46e-05	87	160	6	CID000004184
Drug	Marathon	EPB41L3 LDHA LDHB LDHC MAPK12	3.52e-05	53	160	5	CID000034469
Drug	Thimerosal	SCRN3 ANK2 MYO9A PPFIBP1 GRIK2 ADGRV1 LDHA LGR5 CYP39A1 PDIA3 ITPR3 SLC38A1 KLHL3 SF3B1 DST FNDC11 SYNE2 ITSN2 UHMK1 HADHA PC DOCK6	3.55e-05	1199	160	22	ctd:D013849
Drug	hydroxyisonobilin	LDHA LDHB LDHC	3.94e-05	10	160	3	CID006438562
Drug	pyridinophane cryptand	LDHA LDHB LDHC	3.94e-05	10	160	3	CID006454246
Drug	sodium oxamate	LDHA LDHB LDHC	3.94e-05	10	160	3	CID000005242
Drug	FK3311	LDHA LDHB LDHC	3.94e-05	10	160	3	CID000164009
Drug	2-keto-4-mercaptobutyric acid	LDHA LDHB LDHC	3.94e-05	10	160	3	CID000151198
Drug	bis-NAD	LDHA LDHB LDHC	3.94e-05	10	160	3	CID003081557
Drug	mivazerol	LDHA LDHB LDHC	3.94e-05	10	160	3	CID000060783
Drug	phosphoenolthiopyruvate	LDHA LDHB LDHC	3.94e-05	10	160	3	CID000194910
Drug	cimetidine	ADCY10 LDHA LGR5 CYP39A1 LDHB LDHC ADCY5 TBC1D1	4.03e-05	179	160	8	CID000002756
Drug	fumonisin B	ATP7B LDHA LDHB LDHC S1PR1 PRKD1	4.19e-05	90	160	6	CID000003431
Drug	caffeine	PDE4B CYP26B1 CYP2J2 GRIK2 RAB40A LDHA CYP39A1 LDHB LDHC ADCY5 KRIT1 ITPR3 MAPK12 XRCC6	4.51e-05	562	160	14	CID000002519
Drug	Oxamic Acid	LDHA LDHB	4.91e-05	2	160	2	DB03940
Drug	ingenol dibenzoate	PPARG PRKD1	4.91e-05	2	160	2	ctd:C011875
Drug	hexandiol	LDHA LDHB LDHC	5.39e-05	11	160	3	CID000147023
Drug	5-ethylphenazin-5-ium	LDHA LDHB LDHC	5.39e-05	11	160	3	CID000082689
Drug	hydrazinium nitrate	LDHA LDHB LDHC	5.39e-05	11	160	3	CID000166817
Drug	polyvinylpyridine-N-oxide	LDHA LDHB LDHC	5.39e-05	11	160	3	CID000024772
Drug	Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A	PMS2 MYH10 SREBF2 KRIT1 ITPR3 EDEM3 USP5 ARHGAP19	5.70e-05	188	160	8	4845_DN
Drug	LG61	LDHA LDHB LDHC	7.15e-05	12	160	3	CID000520177
Drug	U74500A	LDHA LDHB LDHC	7.15e-05	12	160	3	CID000107964
Drug	Cotinine (-) [486-56-6]; Up 200; 22.6uM; PC3; HG-U133A	SREBF2 TCIRG1 DENND3 CUL5 KLHL3 USP5 THADA CDK5RAP2	7.64e-05	196	160	8	1929_UP
Drug	methoctramine	PDIA3 ITPR3 UHMK1 PRKD1 PZP	8.14e-05	63	160	5	CID000004108
Drug	alpha-ketobutyrate	LDHA LDHB LDHC HADHA PC	8.78e-05	64	160	5	CID000000058
Drug	allyl alcohol	NFS1 LDHA LDHB LDHC AASS	8.78e-05	64	160	5	CID000007858
Drug	beta-naphthoflavone	CYP2J2 LDHA CYP39A1 LDHB LDHC UGT2B4 UGT2B28 HSP90AA1	8.80e-05	200	160	8	CID000002361
Drug	diphenaldehyde	LDHA LDHB LDHC	9.25e-05	13	160	3	CID000014585
Drug	3-mercaptolactic acid	LDHA LDHB LDHC	9.25e-05	13	160	3	CID000160645
Drug	2-oxohexanoate	LDHA LDHB LDHC	9.25e-05	13	160	3	CID000159664
Drug	T 514	LDHA LDHB LDHC	9.25e-05	13	160	3	CID000114820
Drug	monocrotaline pyrrole	LDHA LDHB PDIA3 LDHC	1.16e-04	36	160	4	CID000104764
Drug	beryllium nitrate	LDHA LDHB LDHC	1.17e-04	14	160	3	CID000026126
Drug	scymnol	LDHA LDHB LDHC	1.17e-04	14	160	3	CID000165531
Drug	AC1L3P2T	LDHA LDHB LDHC	1.17e-04	14	160	3	CID000119585
Drug	AC1O748K	PPARG LDHA LDHB LDHC HADHA	1.26e-04	69	160	5	CID006518413
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.08e-31	46	171	19	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L7 USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L8 USP17L13	4.06e-27	69	171	19	DOID:1682 (implicated_via_orthology)
Disease	sphingomyelin 14:0 measurement	PAK6 THADA SYNE2 ZFHX3	2.44e-06	17	171	4	EFO_0010390
Disease	Malignant neoplasm of breast	KIF6 ATP7B ANK2 PCDHGB6 KALRN OBSCN SREBF2 GRIK2 EPB41L3 RUFY1 LDHB EPG5 CUL5 TGM2 ZNF532 SYNE2 ITSN2 NUP133 HSP90AA1 FOXP3	4.55e-06	1074	171	20	C0006142
Disease	Colorectal Carcinoma	PMS2 ATP7B ANK2 KALRN ABCA13 OBSCN PPARG PAK6 LGR5 TGM2 PANK4 PRKD1 PZP EDRF1	6.42e-05	702	171	14	C0009402
Disease	cortical surface area measurement	KIF6 MYH10 SAMD9 PPFIBP1 ADGRV1 S1PR1 TFAP2B DENND3 SLC38A1 COLEC12 THADA NEO1 SF3B1 ZFHX3 TNKS PRKD1 TAF5 PC XRCC6 WWC1	1.10e-04	1345	171	20	EFO_0010736
Disease	Pseudohypoaldosteronism type 2A	CUL3 KLHL3	1.99e-04	4	171	2	cv:C1840389
Disease	Pseudohypoaldosteronism, type 2	CUL3 KLHL3	1.99e-04	4	171	2	cv:C1449844
Disease	disease of metabolism (implicated_via_orthology)	LDHA LDHB LDHC	2.36e-04	21	171	3	DOID:0014667 (implicated_via_orthology)
Disease	idiopathic osteonecrosis of the femoral head	SAMD9 RIPK1 SYNDIG1 PPARG	2.37e-04	52	171	4	EFO_1001930
Disease	Mammary Carcinoma, Human	ATP7B PCDHGB6 SREBF2 GRIK2 EPB41L3 LDHB CUL5 TGM2 ITSN2 HSP90AA1 FOXP3	2.61e-04	525	171	11	C4704874
Disease	Mammary Neoplasms, Human	ATP7B PCDHGB6 SREBF2 GRIK2 EPB41L3 LDHB CUL5 TGM2 ITSN2 HSP90AA1 FOXP3	2.61e-04	525	171	11	C1257931
Disease	Prostatic Neoplasms	CUL3 SAMD9 ATP7B CDK12 TOM1L1 PAK6 LDHB PDIA3 SF3B1 ATAD3A ITSN2 ZFHX3	2.67e-04	616	171	12	C0033578
Disease	Malignant neoplasm of prostate	CUL3 SAMD9 ATP7B CDK12 TOM1L1 PAK6 LDHB PDIA3 SF3B1 ATAD3A ITSN2 ZFHX3	2.67e-04	616	171	12	C0376358
Disease	Mammary Neoplasms	ATP7B PCDHGB6 SREBF2 GRIK2 EPB41L3 LDHB CUL5 TGM2 ITSN2 HSP90AA1 FOXP3	2.70e-04	527	171	11	C1458155
Disease	Breast Carcinoma	ATP7B PCDHGB6 SREBF2 GRIK2 EPB41L3 LDHB CUL5 TGM2 ITSN2 HSP90AA1 FOXP3	3.21e-04	538	171	11	C0678222
Disease	atopy	ADGRV1 PAK6	3.30e-04	5	171	2	EFO_0002686
Disease	Dyslipidemias	ATP7B PPARG NR5A2	3.54e-04	24	171	3	C0242339
Disease	Dyslipoproteinemias	ATP7B PPARG NR5A2	3.54e-04	24	171	3	C0598784
Disease	Congenital muscular dystrophy (disorder)	SYNE2 POMK	4.93e-04	6	171	2	C0699743
Disease	level of oxylipin in blood plasma	GRIK2 TGM2	6.88e-04	7	171	2	OBA_2050338
Disease	long QT syndrome (is_implicated_in)	ANK2 SNTA1	6.88e-04	7	171	2	DOID:2843 (is_implicated_in)
Disease	Cardiomyopathies, Primary	LDHA ADCY5 NDUFS2 EPG5	7.02e-04	69	171	4	C0033141
Disease	Myocardial Diseases, Secondary	LDHA ADCY5 NDUFS2 EPG5	7.02e-04	69	171	4	C0036529
Disease	phenol sulfate measurement	CYP2J2 PRKD1	9.14e-04	8	171	2	EFO_0021011
Disease	Scoliosis, unspecified	ATAD3A TRAPPC4	9.14e-04	8	171	2	C0036439
Disease	pseudohypoaldosteronism (is_implicated_in)	CUL3 KLHL3	9.14e-04	8	171	2	DOID:4479 (is_implicated_in)
Disease	Sarcomatoid Renal Cell Carcinoma	LDHB TGM2 SYNE2 FMN2 HSPA9	9.18e-04	128	171	5	C1266043
Disease	Chromophobe Renal Cell Carcinoma	LDHB TGM2 SYNE2 FMN2 HSPA9	9.18e-04	128	171	5	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	LDHB TGM2 SYNE2 FMN2 HSPA9	9.18e-04	128	171	5	C1266044
Disease	Papillary Renal Cell Carcinoma	LDHB TGM2 SYNE2 FMN2 HSPA9	9.18e-04	128	171	5	C1306837
Disease	Renal Cell Carcinoma	LDHB TGM2 SYNE2 FMN2 HSPA9	9.18e-04	128	171	5	C0007134
Disease	malignant epithelial tumor of ovary	CHMP4C UGT2B4 WWC1	1.09e-03	35	171	3	MONDO_0018364
Disease	ovarian neoplasm	CHMP4C PMS2 ATP7B CDK12 GRIK2	1.13e-03	134	171	5	C0919267
Disease	underweight body mass index status	ANK2 ADGRB3	1.17e-03	9	171	2	EFO_0005936
Disease	coenzyme Q10 measurement	TOM1L1 GRIK2 COLEC12	1.19e-03	36	171	3	EFO_0007836
Disease	Malignant neoplasm of ovary	CHMP4C PMS2 ATP7B CDK12 GRIK2	1.24e-03	137	171	5	C1140680
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	PDE4B PPARG RUFY1 TFAP2B ADCY5 EDEM3 ZFHX3 TNKS	1.34e-03	364	171	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	cup-to-disc ratio measurement, optic cup area measurement, optic disc area measurement	KIF6 EPB41L3	1.46e-03	10	171	2	EFO_0006937, EFO_0006939, EFO_0006940
Disease	nephritis (implicated_via_orthology)	CYP2J2 SNRPD1	1.46e-03	10	171	2	DOID:10952 (implicated_via_orthology)
Disease	carotid plaque build	EPG5 ITPR3 GFY PRKD1	1.46e-03	84	171	4	EFO_0006501
Disease	skin microbiome measurement	ADGRB3 PPARG THADA	1.50e-03	39	171	3	EFO_0801228
Disease	stroke	ANK2 KALRN EPB41L3 ZFHX3 NIN	1.55e-03	144	171	5	EFO_0000712
Disease	alanine measurement	LDHA LDHC ADCY5 SLC38A1	1.60e-03	86	171	4	EFO_0009765
Disease	neurodegenerative disease (implicated_via_orthology)	UBR2 RASA1 GOSR1 GRIK2 PACSIN2	1.60e-03	145	171	5	DOID:1289 (implicated_via_orthology)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	LDHB TGM2 SYNE2 FMN2 HSPA9	1.75e-03	148	171	5	C0279702
Disease	volumetric bone mineral density	ADGRV1 FHAD1 FMN2	1.86e-03	42	171	3	EFO_0007620
Disease	hepatocellular carcinoma (is_marker_for)	CYP26B1 CDK12 PPARG SLC38A1 SF3B1 ZFHX3 FOXP3	1.94e-03	301	171	7	DOID:684 (is_marker_for)
Disease	Bipolar Disorder	PDE4B ABCA13 CHMP1B GRIK2 LDHA S1PR1 TGM2 PC FOXP3	1.94e-03	477	171	9	C0005586
Disease	Emery-Dreifuss muscular dystrophy (implicated_via_orthology)	LEMD3 SYNE2	2.12e-03	12	171	2	DOID:11726 (implicated_via_orthology)
Disease	N-acetylputrescine measurement	SLC38A1 MAPK12	2.12e-03	12	171	2	EFO_0800127
Disease	Pancreatic Neoplasm	PPARG LDHA TGM2 NR5A2	2.77e-03	100	171	4	C0030297
Disease	Malignant neoplasm of pancreas	PPARG LDHA TGM2 NR5A2	2.98e-03	102	171	4	C0346647
Disease	upper aerodigestive tract neoplasm	SCGN PDIA3 TBC1D1 ZFHX3 TNKS APBB1IP	3.20e-03	246	171	6	EFO_0004284
Disease	acute graft vs. host disease, donor genotype effect measurement	SLC25A24 KALRN	3.34e-03	15	171	2	EFO_0004599, EFO_0007892
Disease	Romano-Ward Syndrome	ANK2 SNTA1	3.80e-03	16	171	2	C0035828
Disease	4-acetamidobutanoate measurement	SLC38A1 MAPK12	3.80e-03	16	171	2	EFO_0021003
Disease	body mass index, type 2 diabetes mellitus	PPARG ADCY5	3.80e-03	16	171	2	EFO_0004340, MONDO_0005148
Disease	IGFBP-3 measurement	PAK6 ATRIP PANK4	3.82e-03	54	171	3	EFO_0004626
Disease	skin aging measurement	PPARG SLC38A1 MMAA SYNE2 PRKD1	4.16e-03	181	171	5	EFO_0008006
Disease	body fat percentage, type 2 diabetes mellitus	PPARG ADCY5	4.29e-03	17	171	2	EFO_0007800, MONDO_0005148
Disease	Antibody Deficiency Syndrome	ZAP70 EPG5	4.29e-03	17	171	2	C0003257
Disease	phosphatidylcholine 36:4 measurement	UGT2B4 UGT2B28	4.81e-03	18	171	2	EFO_0010382
Disease	insulin resistance	ANK2 PPARG SLC38A1	4.90e-03	59	171	3	EFO_0002614
Disease	HMG CoA reductase inhibitor use measurement	PPARG ITPR3 SLC38A1 DOCK6 SNTA1	4.99e-03	189	171	5	EFO_0009932
Disease	Chronic myeloproliferative disorder	ORC4 ATRIP	5.35e-03	19	171	2	C1292778
Disease	squamous cell carcinoma (is_marker_for)	RIPK1 XRCC6	5.35e-03	19	171	2	DOID:1749 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KDLHPDQMLMEAFFK	EPG5	2061	Q9HCE0
FSEDHIKSFMKQLME	CDK12	831	Q9NYV4
EKLHLMFSLMDKVPN	CUL5	291	Q93034
MREHIFKKNGLIMSS	CYP2J2	116	P51589
GHFLKNESSEVKSMM	ADGRG4	161	Q8IZF6
KEEFGMMGDHTIKSQ	ADGRB3	251	O60242
EMAHKIKTVMFDKTG	ATP7B	1016	P35670
KKLALHSGMDYAIMT	ATAD3A	411	Q9NVI7
GLDHMLAMETIDKAK	AASS	606	Q9UDR5
GEQDFMSDLMKALQK	APBB1IP	646	Q7Z5R6
FAAKLLTHMMAASLG	ADGRV1	5936	Q8WXG9
FHGDMKLSREMIKFS	CNTNAP4	1031	Q9C0A0
EKSTHNLLSLFMMLQ	ABCA13	2016	Q86UQ4
HDLKSLMETMKQPFL	CDK11B	521	P21127
GHDLIMKMKIQLSEA	DNAJA4	256	Q8WW22
KTHQATLGNMMDKLA	C6orf163	241	Q5TEZ5
THIKALADFAMKLMD	ADCY5	1146	O95622
AIKKMAMSHGFKTEE	ADCY10	991	Q96PN6
AMNGHTAAVKLLLDM	ANKRD17	1226	O75179
KHMQLGDFMKRVQES	DENND3	646	A2RUS2
LRNMGFAAKAMKSVH	CHMP4C	106	Q96CF2
FAAKAMKSVHENMDL	CHMP4C	111	Q96CF2
LTEALKGMDKMFLNN	TFAP2B	421	Q92481
ESKLSEMKKMHEGDL	CDK5RAP2	196	Q96SN8
SNLREDKKHQEMMGL	CCDC27	486	Q2M243
EMMTKQLGAHLEQLK	CFAP206	291	Q8IYR0
MRALAKTKGMSLSEH	POLL	516	Q9UGP5
HLKSFSMAKGLNARM	RAB40A	221	Q8WXH6
HLKSFSMAKGLNARM	RAB40AL	221	P0C0E4
HTKMLQITNTGFEMK	PZP	301	P20742
KSNKHRMIMFLDELG	RASA1	961	P20936
EFILAMHLTDMAKAG	ITSN2	301	Q9NZM3
KGDAKMMEILRYTHQ	ITPR3	1216	Q14573
YNDKASLAHLLDMMK	ITPR3	1336	Q14573
SFHNLMMSDKKSERF	ITPR3	1771	Q14573
QSTKHMFSLDEKTGM	PCDHGB6	286	Q9Y5F9
DKLKGEMMDLQHGSL	LDHA	56	P00338
ESEKTLMMNTLYKLH	LEMD3	521	Q9Y2U8
DMVTLLLDKGANIHM	ANK2	676	Q01484
NHLKDMTKNMGVIAE	ANO6	881	Q4KMQ2
MNLEKISALMDKFEH	CHMP1B	106	Q7LBR1
SGKTMLINHALKELM	ORC4	71	O43929
LEDKMKAHSFLMDFI	NUP133	601	Q8WUM0
EKHSGRQVAVKMMDL	PAK6	426	Q9NQU5
KLHGDMLEMILSSEK	PRKD1	661	Q15139
GMLKSIHSKMNTLAN	GOSR1	196	O95249
DMKIDLMSISGHKIY	NFS1	246	Q9Y697
EKLSAMQAHLAGKMA	FOXP3	251	Q9BZS1
MQAHLAGKMALTKAS	FOXP3	256	Q9BZS1
EHKGELQTDKMMRAA	WWC1	1056	Q8IX03
NLTHMLKEDDMFKDF	PPFIBP1	981	Q86W92
EKQMALFLDKMGSLQ	EDRF1	651	Q3B7T1
KLKSLQKEMDQHFGM	DST	4996	Q03001
EHGKEMTMQELKDGT	CYP26B1	276	Q9NR63
DHLLTHEKTMFKDLM	DOP1B	1996	Q9Y3R5
FMATNPEHLEILKKM	EDEM3	581	Q9BZQ6
HEALGISMAKVLMAF	EIF2B5	656	Q13144
ATDMSKHMSLLADLK	PDE4B	516	Q07343
MEEMKLVDSKHGQLI	COLEC12	421	Q5KU26
KKANDAMHVSMLEGF	KALRN	1451	O60229
SSLLHKKIGMREEMS	KIF6	541	Q6ZMV9
DKLKGEMMDLQHGSL	LDHC	56	P07864
TGHDLGDKIMALKME	LURAP1	51	Q96LR2
LHMGYSALEIKSKML	KRIT1	206	O00522
KMKDFQDLMLASGEL	MMAA	341	Q8IVH4
KMLSVKVMRDNSGHS	PABPC1L	216	Q4VXU2
GNHMTMSVLRKIFVK	PRSS54	176	Q6PEW0
LMKMKETAENYLGHT	HSPA9	171	P38646
DKMSKGHMLADVVAI	NDUFS2	436	O75306
FSKEDMAKSLLHMIS	PANK4	286	Q9NVE7
SEKFKMSLEGQMAEL	OBSCN	2511	Q5VST9
HKQMMGGFKETKEAE	PACSIN2	121	Q9UNF0
ELGAMHMLSSIQKAA	BECN2	86	A8MW95
LHGADMMTKNLAGKT	ANKRD2	301	Q9GZV1
KTLGSLMNIKNMSGH	FHAD1	1251	B1AJZ9
IFHEVPLKFMMSKNT	ICE2	341	Q659A1
FNLHMILTDTVKMKE	DOCK6	1556	Q96HP0
MGHLMKVKERQAATD	DNAH17	1126	Q9UFH2
ESLDMPKTNLSKMAH	GFY	116	I3L273
MSTHVAGLGLDKMKL	FNDC11	1	Q9BVV2
KHMKTIVEMENSGLV	CUL3	271	Q13618
GHMLKFLEVKFGLNM	DPY19L4	376	Q7Z388
VMTKESKALMGLYHG	HADHA	331	P40939
AHMGKAFKVMNELRS	KLHL3	31	Q9UH77
EDKLKGEMMDLQHGS	LDHB	56	P07195
GQDMTLKKHVFFMNS	SLC44A3	86	Q8N4M1
IMLKGKMGTVNLHQF	CYP39A1	121	Q9NYL5
DNSTMGYMAAKKHLE	HSP90AA1	621	P07900
LLHGLSQKDKLFMMH	ATRIP	726	Q8WXE1
MHFSVKTLEIQMKAF	CCDC168	6551	Q8NDH2
LSKSMMEASFFKHPD	FAM216A	91	Q8WUB2
SHEMAAGILKQALAM	GRIK2	231	Q13002
QAVGILMSSLHLDMK	FMN2	1366	Q9NZ56
ELDAFFLHMLMKLGT	SCGN	36	O76038
MKLGTDDTVMKANLH	SCGN	46	O76038
SFDLQKSEDMLRKHM	SEC14L6	46	B5MCN3
ERYITMLKMKLHNGS	S1PR1	141	P21453
KMHEEQELFTEKMRG	CFAP74	86	Q9C0B2
EAEMHFLENAKKLSM	EPB41L3	281	Q9Y2J2
MGFSHEEILSMLKVV	MYH10	336	P35580
IMHLSGIKDISKFAM	FAM8A1	271	Q9UBU6
SSMDDLHKKDAGMFQ	LGR5	501	O75473
LAGIIMKQMSTHYLK	MROH2A	1611	A6NES4
HEKLSTFGLMCKMAD	NR5A2	336	O00482
TKKEHMKGNETMLDF	TAF5	286	Q15542
NMGEKFLLLAMKENH	THADA	1586	Q6YHU6
QIGKLHSELDMVKMN	TOM1L1	201	O75674
NEKLMLASMFHSLFA	TRAPPC4	106	Q9Y296
PRNFSEAKHMSLKMA	SNTA1	206	Q13424
MEESLKHLIAKGSMF	SYNE2	766	Q8WXH0
KHLIAKGSMFDELMA	SYNE2	771	Q8WXH0
MDGIIEQKSMLVHSK	SYNDIG1	1	Q9H7V2
VLSHGEKEEELKAMM	NIN	1481	Q8N4C6
LAALHNMAEMKTSLF	NKX6-2	16	Q9C056
GMGKSKFLQDMHTLL	SAMD9	1021	Q5K651
MASIKMKENHEFDGK	SLC27A2	526	O14975
LLNKHKGNITFETMM	SCRN3	246	Q0VDG4
NRVMMVAKKFLDAGH	PDIA3	281	P30101
QEMGLHLSQSKLKME	RUFY1	611	Q96T51
NSLMMGEDKIKFKHI	PPARG	281	P37231
FVMEHLKMKSLSSQA	FN3K	86	Q9H479
LTKEMAHLEGLMKDL	NEO1	1441	Q92859
LENFMAIEEMKKHGS	POTEJ	496	P0CG39
REFGKTITHIVAKMM	SHCBP1L	376	Q9BZQ2
RAKSMKFVDGLMIHS	RPS3	146	P23396
TSLEMKDDFLHGLQM	POMK	111	Q9H5K3
EKGNLMHVLKAEMST	RIPK1	96	Q13546
MVKSLMHLGKFEKNV	ST18	126	O60284
HLNKLAEKEETGMAM	TGM2	461	P21980
SHLLGKDKMSQMASV	TEX44	126	Q53QW1
LGDTAMQKMAKSHVF	UBA6	51	A0AVT1
VHEFLMFTVDAMKKA	USP17L3	161	A6NCW0
DVQFKMSHKRIMLFT	XRCC6	156	P12956
LKSSQGFMHMKLSRT	SHF	361	Q7M4L6
HGMAFIKSKRMSSAE	ZNF532	1286	Q9HCE3
LLHQVSMGMKYLEEK	ZAP70	441	P43403
VHEFLMFTVDAMKKA	USP17L4	161	A6NCW7
MKGHFDNLFSKMEQL	MIS12	71	Q9H081
KVFGTHLMQDMVKDA	NAA35	381	Q5VZE5
MKAKGAAVSLDFHTM	UGT2B4	406	P06133
VMKTCQEEKLMGHLG	SF3B1	961	O75533
LGKSFLQFSTMKMAH	TNKS	1256	O95271
IELKDLVMGTDAKMH	SREBF2	351	Q12772
LVMGTDAKMHKSGVL	SREBF2	356	Q12772
LLHMSEEEAFKMLKF	TBC1D1	901	Q86TI0
AHEFLMFTVDAMKKA	USP17L18	161	D6R9N7
AHEFLMFTVDAMKKA	USP17L5	161	A8MUK1
AHEFLMFTVDAMKKA	USP17L21	161	D6R901
AHEFLMFTVDAMKKA	USP17L13	161	C9JLJ4
GVDVSMNTHLKAVKM	SNRPD1	31	P62314
AHEFLMFTVDAMKKA	USP17L19	161	D6RCP7
LMMLQKGGEEKSHEK	TRAV34	66	A0A0B4J273
ELRLHLMASSGKMFK	VPS13C	1971	Q709C8
MILSLKTMDRFDDHK	ATP6AP1	446	Q15904
TKLNSGMAFMIKHSQ	ARHGAP19	291	Q14CB8
VHEFLMFTVDAMKKA	USP17L1	161	Q7RTZ2
ALNTSEMKKLITHMG	PMS2	821	P54278
AHEFLMFTVDAMKKA	USP17L12	161	C9JPN9
MKAEIKDGLEFMQHS	TTC38	226	Q5R3I4
AHEFLMFTVDAMKKA	USP17L24	161	Q0WX57
AHEFLMFTVDAMKKA	USP17L7	161	P0C7H9
AHEFLMFTVDAMKKA	USP17L8	161	P0C7I0
MPDFLEKLHMATLKA	STARD7	311	Q9NQZ5
AHEFLMFTVDAMKKA	USP17L6P	161	Q6QN14
MKAKGAAVRLDFHTM	UGT2B28	406	Q9BY64
MHLVTNSGKMVVLDK	SMARCA5	476	O60264
AHEFLMFTVDAMKKA	USP17L22	161	D6RA61
HQLFMSSLLMDLKYK	UBR2	371	Q8IWV8
AHEFLMFTVDAMKKA	USP17L15	161	C9J2P7
AHEFLMFTVDAMKKA	USP17L17	161	D6RBQ6
SILVKDTQAMKEMHF	PC	1086	P11498
KMHIEAAKMLSFTEE	TEX9	366	Q8N6V9
ILLEMFSGMKLKHTV	UHMK1	231	Q8TAS1
MMHFKSGLELTELQN	SLC38A1	1	Q9H2H9
DRLKIMMQVHGSKSD	SLC25A24	216	Q6NUK1
LSHFGIDMLKMQKTD	USP5	276	P45974
AHEFLMFTVDAMKKA	USP17L2	161	Q6R6M4
NSFKMKMSVILGVVH	TCIRG1	531	Q13488
AHEFLMFTVDAMKKA	USP17L20	161	D6RJB6
NKFTTDNLDMLGLHM	ZFHX3	951	Q15911
AHEFLMFTVDAMKKA	USP17L11	161	C9JVI0
FMGTDLGKLMKHEKL	MAPK12	111	P53778
SSAEHLKDGTMKEMV	MYO9A	1381	B2RTY4